Clinical trials: Placenta, Retained
Postpartum Haemorrhage, Retained Placenta
Two Different Regimens of Misoprostol in Retained Placenta
This study evaluates intra umbilical vein injection of 800 µg versus 400 µg misoprostol for the treatment of retained placenta to reduce the need of manual removal of placenta under general anaesthesia
- Trial name
- NCT02704780
- Testing
- Misoprostol
- Where
- Iraq
- Volunteers
- 509 people, healthy volunteers welcome
- Sponsor
- Hawler Medical University
CARBETOCIN FOR PREVENTION OF PLACENTAL RETAINED
Randomized Clinical Trial for Comparison Of Intravenous Carbeitocin Versus Oxytocin In Management Of Placental Delivery In Second Trimester Interruption
Intravenous Carbetocin is more efficient than intravenous infusion oxytocin in management of placental delivery in 2nd trimester interruption.
- Trial name
- NCT01827124
- Testing
- Carbetocin, oxytocin
- Where
- Egypt
- Volunteers
- 140 people, healthy volunteers welcome
- Sponsor
- Wafaa Uthman Ahmed
Puerperal Sepsis, Postpartum Hemorrhage
Assessing Childbirth-related Complications at the Community Level in Kenya
Kenya is one of the countries in sub-Saharan Africa that still experience high maternal mortality. For instance, in 2008/09 maternal mortality ratio was estimated to be 488/100,000 live births.
- Conditions
- Puerperal Sepsis, Postpartum Hemorrhage, Preeclampsia and Eclampsia, Retained Placenta, Without Hemorrhage
- Trial name
- NCT01665456
- Where
- Kenya
- Volunteers
- 585 people, healthy volunteers welcome
- Sponsor
- Wilson Liambila